Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Robust Antibody and Cytokine Response to Hepatitis B Vaccine Among Not-in-treatment Patients With Chronic Hepatitis C：An Open-label Control Study in China [Phase 4]
This Phase 4 open-label study in China evaluated the antibody and cytokine response to the Hepatitis B vaccine in patients with chronic hepa…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues [Phase 4]
A Phase 4 clinical trial update assessing the efficacy of peginterferon alfa-2a in chronic hepatitis B patients who are receiving nucleos(t)…
-
CLINICAL_TRIALS trial_result · 2016-09-13Clinical Trial Update: Lamivudine(LAM) Good Responder Study
Completed clinical trial update on lamivudine for chronic hepatitis B, focusing on good responders.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of Age [Phase 3]
Phase 3 trial update reports immunogenicity and safety findings for a novel adjuvanted hepatitis B vaccine in adults awaiting liver transpla…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects. [Phase 2]
Phase 2 trial by GlaxoSmithKline evaluated antibody persistence and booster response, as well as safety, in individuals previously primed wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters
A completed prospective clinical trial evaluating non-invasive parameters to assess hepatic fibrosis in patients with hepatitis B virus infe…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants [Phase 3]
Phase 3 trial evaluating the immunogenicity and reactogenicity of GSK DTPa-HBV-IPV and Hib vaccines when coadministered to healthy infants.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B Vaccine [Phase 3]
Long-term follow-up from Phase 3 trials to demonstrate the equivalence of two vaccination schedules for the combined Hepatitis A & B vaccine…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine [Phase 3]
A Phase 3 trial evaluated the immunogenicity and safety of primary and booster vaccination with GlaxoSmithKline's DTPa-HBV-IPV/Hib hexavalen…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: Immune Function Status and the Prevalence of Hepatitis in Postpartum Pregnant Women With CHB Infection
A clinical trial update evaluating immune function and the prevalence of hepatitis in postpartum pregnant women with chronic hepatitis B inf…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment
This clinical trial update reports sustained viral response in patients with chronic hepatitis B who achieved HBsAg levels at 100 IU/mL or l…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients
The document reports efficacy results from a trial of extended peginterferon alfa-2a treatment in HBeAg-negative chronic hepatitis B patient…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment [Phase 4]
A Phase 4 trial evaluating whether adding entecavir to ongoing peginterferon alfa-2a improves efficacy in HBeAg-negative, HBV DNA-positive c…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment [Phase 4]
The update details a Phase 4 study evaluating adding entecavir to ongoing peginterferon alfa-2a in HBeAg-positive, HBV DNA-positive chronic …
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy
This clinical trial update reports on sustained viral response in chronic hepatitis B patients who achieved HBeAg seroconversion after inter…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B [Phase 3]
Phase 3 trial comparing Pegasys (peginterferon alfa-2a) to untreated control in children with HBeAg-positive chronic hepatitis B; completed …
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon
A completed cohort study in Korean patients with chronic hepatitis B evaluating pegylated interferon therapy.
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection [Phase 2]
A Phase 2 study of pamrevlumab (FG-3019) for liver fibrosis due to chronic hepatitis B infection was terminated.
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine [Phase 3]
Phase 3 trial update evaluating the immunogenicity and reactogenicity of the DTPa-HBV-IPV/Hib vaccine given in a schedule with subsequent va…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Added to Nucleos(t)Ide Analogue Treatment in Participants With HBeAg-Negative Chronic Hepatitis B Genotype D Showing Stable Hepatitis B Virus (HBV) Deoxyribonucleic Acid (DNA) Suppression [Phase 2]
Phase 2 study evaluating the addition of Pegasys (peginterferon alfa-2a) to nucleos(t)ide analogue therapy in adults with HBeAg-negative chr…
-
CLINICAL_TRIALS trial_result · 2016-08-05Clinical Trial Update: Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course [Phase 4]
Phase 4 trial comparing immunogenicity and reactogenicity of INFANRIX HEXA and INFANRIX HEXAVAC as a primary vaccination course; completed s…
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: Pharmacokinetics of Two Formulations of Entecavir [Phase 4]
This clinical trial update compares the pharmacokinetics of two formulations of entecavir in patients with Hepatitis B.
-
CLINICAL_TRIALS trial_result · 2016-07-22Clinical Trial Update: An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B [Phase 4]
Expanded-access study of Pegasys (peginterferon alfa-2a) in HBeAg-negative chronic hepatitis B completed the Phase 4 protocol, with results …
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2) [Phase 3]
Phase 3 trial evaluating lamivudine plus a therapeutic hepatitis B vaccine in Senegalese patients with chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age
GlaxoSmithKline-sponsored clinical trial evaluating the incidence of Hepatitis B diagnosis among diabetes mellitus patients aged 0-80 years …